IMAGE: IMAGE MAY BE REPRODUCED FOR NEWS ARTICLES/BROADCAST UNDER THE FOLLOWING TERMS OF USE: • IMAGE MUST ONLY BE USED FOR NEWS ARTICLES RELATED TO VCAT • NO CHANGES CAN BE MADE TO THE IMAGE OR INSTRUCTIONS, EXCEPT FOR TRANSLATION OF INSTRUCTIONS INTO THE LANGUAGE OF THE PUBLICATION/BROADCAST • TO INCLUDE THE FOLLOWING ATTRIBUTION: VISUAL...
Share on Pinterest A recent, small-scale study tests whether light therapy improves cognition in people with mild cognitive impairment. franconiaphoto/Getty Images Researchers are investigating infrared light as a treatment for various brain conditions. Scientists have designed helmets that include light therapy, known as photobiomodulation (PBM) devices, which people can wear at home. A recent study...
by University of Plymouth Credit: Unsplash/CC0 Public Domain A drug used to treat agitation in people with dementia is no more effective than a placebo, and might even increase mortality, according to a new study. The research, led by the University of Plymouth and published in The Lancet, has shown that antidepressant mirtazapine offered no improvement in...
by Durham University Tracy Sloan with the infrared light therapy helmet. Tracy used the helmet to try and help improve her memory. Credit: Durham University/North News & Pictures Infrared light therapy might have the potential to help people living with dementia, according to researchers. A pilot study, led by Dr. Paul Chazot, Durham University, UK, and...
by Will Doss, Northwestern University A T-cell (red) interacting with an alpha-synuclein Lewy neurite (green) adjacent to a dopaminergic neuron (magenta) in a Parkinson’s disease brain. Credit: Northwestern University T-cells respond to buildups of alpha-synuclein, the aggregated protein clumps that are a feature of neurodegenerative diseases including dementia with Lewy bodies and Parkinson’s disease (PD), according...
By Nick Lavars October 11, 2021 Red blood cells in vein or artery, flow inside a living organism. 3d renderingRost9/Depositphotos Earlier detection of dementia could open up far more effective ways to treat and manage the condition, and one place scientists are increasingly turning to for warning signs is the blood. A new study has...
by German Center for Neurodegenerative Diseases Credit: CC0 Public Domain Researchers at the DZNE and the University Medical Center Göttingen (UMG) have identified molecules in the blood that can indicate impending dementia. Their findings, which are presented in the scientific journal EMBO Molecular Medicine, are based on human studies and laboratory experiments. University hospitals across Germany were...
Interview conducted by Emily Henderson, B.Sc.Oct 6, 2021 Thought LeadersDr. Yana VinogradovaSenior Research FellowUniversity of Nottingham In this interview, News-Medical speaks to Dr. Yana Vinogradova about her latest research into menopausal hormone therapy (MHT) and its unassociated risk to dementia. What provoked your latest research into menopausal hormone therapy (MHT) and dementia? We have been...
Share on Pinterest New research in mice may help open up new treatment avenues for Alzheimer’s disease. Maskot/Getty Images Worldwide, Alzheimer’s disease is one of the most common forms of dementia. Using mouse models, researchers in Australia have identified one of the likely causes of Alzheimer’s disease. Some have dubbed the finding a “breakthrough.” By studying the blood-brain...
by University of Sheffield Credit: Unsplash/CC0 Public Domain Researchers from the University of Sheffield have discovered a new gene therapy pathway that has uncovered an important regulatory mechanism to keep our genome healthy. This pathway has the potential to protect us against serious life-limiting diseases such as cancer and dementia. Cancer and neurodegeneration are two major health...
